Global Oncolytic Virus Immunotherapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Oncolytic Virus Immunotherapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Oncolytic Virus Immunotherapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Oncolytic Virus Immunotherapy market. Oncolytic Virus Immunotherapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncolytic Virus Immunotherapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncolytic Virus Immunotherapy market.
Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
Key Features:
The report on Oncolytic Virus Immunotherapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncolytic Virus Immunotherapy market. It may include historical data, market segmentation by Type (e.g., Engineering Oncolytic Viruses, Wild-Type Oncolytic Viruses), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncolytic Virus Immunotherapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncolytic Virus Immunotherapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncolytic Virus Immunotherapy industry. This include advancements in Oncolytic Virus Immunotherapy technology, Oncolytic Virus Immunotherapy new entrants, Oncolytic Virus Immunotherapy new investment, and other innovations that are shaping the future of Oncolytic Virus Immunotherapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncolytic Virus Immunotherapy market. It includes factors influencing customer ' purchasing decisions, preferences for Oncolytic Virus Immunotherapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncolytic Virus Immunotherapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncolytic Virus Immunotherapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncolytic Virus Immunotherapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncolytic Virus Immunotherapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncolytic Virus Immunotherapy market.
Market Segmentation:
Oncolytic Virus Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Oncolytic Virus Immunotherapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Oncolytic Virus Immunotherapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Oncolytic Virus Immunotherapy market. Oncolytic Virus Immunotherapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncolytic Virus Immunotherapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncolytic Virus Immunotherapy market.
Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
Key Features:
The report on Oncolytic Virus Immunotherapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncolytic Virus Immunotherapy market. It may include historical data, market segmentation by Type (e.g., Engineering Oncolytic Viruses, Wild-Type Oncolytic Viruses), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncolytic Virus Immunotherapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncolytic Virus Immunotherapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncolytic Virus Immunotherapy industry. This include advancements in Oncolytic Virus Immunotherapy technology, Oncolytic Virus Immunotherapy new entrants, Oncolytic Virus Immunotherapy new investment, and other innovations that are shaping the future of Oncolytic Virus Immunotherapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncolytic Virus Immunotherapy market. It includes factors influencing customer ' purchasing decisions, preferences for Oncolytic Virus Immunotherapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncolytic Virus Immunotherapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncolytic Virus Immunotherapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncolytic Virus Immunotherapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncolytic Virus Immunotherapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncolytic Virus Immunotherapy market.
Market Segmentation:
Oncolytic Virus Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Engineering Oncolytic Viruses
- Wild-Type Oncolytic Viruses
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Amgen
- TILT Biotherapeutics
- Oncorus
- Sorrento Therapeutics
- Shanghai Sunway Biotech
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Immunotherapy Market Size 2019-2030
2.1.2 Oncolytic Virus Immunotherapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oncolytic Virus Immunotherapy Segment by Type
2.2.1 Engineering Oncolytic Viruses
2.2.2 Wild-Type Oncolytic Viruses
2.3 Oncolytic Virus Immunotherapy Market Size by Type
2.3.1 Oncolytic Virus Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
2.4 Oncolytic Virus Immunotherapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.5 Oncolytic Virus Immunotherapy Market Size by Application
2.5.1 Oncolytic Virus Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
3 ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Oncolytic Virus Immunotherapy Market Size Market Share by Players
3.1.1 Global Oncolytic Virus Immunotherapy Revenue by Players (2019-2024)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS IMMUNOTHERAPY BY REGIONS
4.1 Oncolytic Virus Immunotherapy Market Size by Regions (2019-2024)
4.2 Americas Oncolytic Virus Immunotherapy Market Size Growth (2019-2024)
4.3 APAC Oncolytic Virus Immunotherapy Market Size Growth (2019-2024)
4.4 Europe Oncolytic Virus Immunotherapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Oncolytic Virus Immunotherapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oncolytic Virus Immunotherapy Market Size by Country (2019-2024)
5.2 Americas Oncolytic Virus Immunotherapy Market Size by Type (2019-2024)
5.3 Americas Oncolytic Virus Immunotherapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Immunotherapy Market Size by Region (2019-2024)
6.2 APAC Oncolytic Virus Immunotherapy Market Size by Type (2019-2024)
6.3 APAC Oncolytic Virus Immunotherapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus Immunotherapy by Country (2019-2024)
7.2 Europe Oncolytic Virus Immunotherapy Market Size by Type (2019-2024)
7.3 Europe Oncolytic Virus Immunotherapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus Immunotherapy by Region (2019-2024)
8.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET FORECAST
10.1 Global Oncolytic Virus Immunotherapy Forecast by Regions (2025-2030)
10.1.1 Global Oncolytic Virus Immunotherapy Forecast by Regions (2025-2030)
10.1.2 Americas Oncolytic Virus Immunotherapy Forecast
10.1.3 APAC Oncolytic Virus Immunotherapy Forecast
10.1.4 Europe Oncolytic Virus Immunotherapy Forecast
10.1.5 Middle East & Africa Oncolytic Virus Immunotherapy Forecast
10.2 Americas Oncolytic Virus Immunotherapy Forecast by Country (2025-2030)
10.2.1 United States Oncolytic Virus Immunotherapy Market Forecast
10.2.2 Canada Oncolytic Virus Immunotherapy Market Forecast
10.2.3 Mexico Oncolytic Virus Immunotherapy Market Forecast
10.2.4 Brazil Oncolytic Virus Immunotherapy Market Forecast
10.3 APAC Oncolytic Virus Immunotherapy Forecast by Region (2025-2030)
10.3.1 China Oncolytic Virus Immunotherapy Market Forecast
10.3.2 Japan Oncolytic Virus Immunotherapy Market Forecast
10.3.3 Korea Oncolytic Virus Immunotherapy Market Forecast
10.3.4 Southeast Asia Oncolytic Virus Immunotherapy Market Forecast
10.3.5 India Oncolytic Virus Immunotherapy Market Forecast
10.3.6 Australia Oncolytic Virus Immunotherapy Market Forecast
10.4 Europe Oncolytic Virus Immunotherapy Forecast by Country (2025-2030)
10.4.1 Germany Oncolytic Virus Immunotherapy Market Forecast
10.4.2 France Oncolytic Virus Immunotherapy Market Forecast
10.4.3 UK Oncolytic Virus Immunotherapy Market Forecast
10.4.4 Italy Oncolytic Virus Immunotherapy Market Forecast
10.4.5 Russia Oncolytic Virus Immunotherapy Market Forecast
10.5 Middle East & Africa Oncolytic Virus Immunotherapy Forecast by Region (2025-2030)
10.5.1 Egypt Oncolytic Virus Immunotherapy Market Forecast
10.5.2 South Africa Oncolytic Virus Immunotherapy Market Forecast
10.5.3 Israel Oncolytic Virus Immunotherapy Market Forecast
10.5.4 Turkey Oncolytic Virus Immunotherapy Market Forecast
10.5.5 GCC Countries Oncolytic Virus Immunotherapy Market Forecast
10.6 Global Oncolytic Virus Immunotherapy Forecast by Type (2025-2030)
10.7 Global Oncolytic Virus Immunotherapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Oncolytic Virus Immunotherapy Product Offered
11.1.3 Merck Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Oncolytic Virus Immunotherapy Product Offered
11.2.3 Amgen Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 TILT Biotherapeutics
11.3.1 TILT Biotherapeutics Company Information
11.3.2 TILT Biotherapeutics Oncolytic Virus Immunotherapy Product Offered
11.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 TILT Biotherapeutics Main Business Overview
11.3.5 TILT Biotherapeutics Latest Developments
11.4 Oncorus
11.4.1 Oncorus Company Information
11.4.2 Oncorus Oncolytic Virus Immunotherapy Product Offered
11.4.3 Oncorus Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Oncorus Main Business Overview
11.4.5 Oncorus Latest Developments
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Information
11.5.2 Sorrento Therapeutics Oncolytic Virus Immunotherapy Product Offered
11.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sorrento Therapeutics Main Business Overview
11.5.5 Sorrento Therapeutics Latest Developments
11.6 Shanghai Sunway Biotech
11.6.1 Shanghai Sunway Biotech Company Information
11.6.2 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product Offered
11.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Shanghai Sunway Biotech Main Business Overview
11.6.5 Shanghai Sunway Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Immunotherapy Market Size 2019-2030
2.1.2 Oncolytic Virus Immunotherapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oncolytic Virus Immunotherapy Segment by Type
2.2.1 Engineering Oncolytic Viruses
2.2.2 Wild-Type Oncolytic Viruses
2.3 Oncolytic Virus Immunotherapy Market Size by Type
2.3.1 Oncolytic Virus Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
2.4 Oncolytic Virus Immunotherapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.5 Oncolytic Virus Immunotherapy Market Size by Application
2.5.1 Oncolytic Virus Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
3 ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Oncolytic Virus Immunotherapy Market Size Market Share by Players
3.1.1 Global Oncolytic Virus Immunotherapy Revenue by Players (2019-2024)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS IMMUNOTHERAPY BY REGIONS
4.1 Oncolytic Virus Immunotherapy Market Size by Regions (2019-2024)
4.2 Americas Oncolytic Virus Immunotherapy Market Size Growth (2019-2024)
4.3 APAC Oncolytic Virus Immunotherapy Market Size Growth (2019-2024)
4.4 Europe Oncolytic Virus Immunotherapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Oncolytic Virus Immunotherapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oncolytic Virus Immunotherapy Market Size by Country (2019-2024)
5.2 Americas Oncolytic Virus Immunotherapy Market Size by Type (2019-2024)
5.3 Americas Oncolytic Virus Immunotherapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Immunotherapy Market Size by Region (2019-2024)
6.2 APAC Oncolytic Virus Immunotherapy Market Size by Type (2019-2024)
6.3 APAC Oncolytic Virus Immunotherapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus Immunotherapy by Country (2019-2024)
7.2 Europe Oncolytic Virus Immunotherapy Market Size by Type (2019-2024)
7.3 Europe Oncolytic Virus Immunotherapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus Immunotherapy by Region (2019-2024)
8.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET FORECAST
10.1 Global Oncolytic Virus Immunotherapy Forecast by Regions (2025-2030)
10.1.1 Global Oncolytic Virus Immunotherapy Forecast by Regions (2025-2030)
10.1.2 Americas Oncolytic Virus Immunotherapy Forecast
10.1.3 APAC Oncolytic Virus Immunotherapy Forecast
10.1.4 Europe Oncolytic Virus Immunotherapy Forecast
10.1.5 Middle East & Africa Oncolytic Virus Immunotherapy Forecast
10.2 Americas Oncolytic Virus Immunotherapy Forecast by Country (2025-2030)
10.2.1 United States Oncolytic Virus Immunotherapy Market Forecast
10.2.2 Canada Oncolytic Virus Immunotherapy Market Forecast
10.2.3 Mexico Oncolytic Virus Immunotherapy Market Forecast
10.2.4 Brazil Oncolytic Virus Immunotherapy Market Forecast
10.3 APAC Oncolytic Virus Immunotherapy Forecast by Region (2025-2030)
10.3.1 China Oncolytic Virus Immunotherapy Market Forecast
10.3.2 Japan Oncolytic Virus Immunotherapy Market Forecast
10.3.3 Korea Oncolytic Virus Immunotherapy Market Forecast
10.3.4 Southeast Asia Oncolytic Virus Immunotherapy Market Forecast
10.3.5 India Oncolytic Virus Immunotherapy Market Forecast
10.3.6 Australia Oncolytic Virus Immunotherapy Market Forecast
10.4 Europe Oncolytic Virus Immunotherapy Forecast by Country (2025-2030)
10.4.1 Germany Oncolytic Virus Immunotherapy Market Forecast
10.4.2 France Oncolytic Virus Immunotherapy Market Forecast
10.4.3 UK Oncolytic Virus Immunotherapy Market Forecast
10.4.4 Italy Oncolytic Virus Immunotherapy Market Forecast
10.4.5 Russia Oncolytic Virus Immunotherapy Market Forecast
10.5 Middle East & Africa Oncolytic Virus Immunotherapy Forecast by Region (2025-2030)
10.5.1 Egypt Oncolytic Virus Immunotherapy Market Forecast
10.5.2 South Africa Oncolytic Virus Immunotherapy Market Forecast
10.5.3 Israel Oncolytic Virus Immunotherapy Market Forecast
10.5.4 Turkey Oncolytic Virus Immunotherapy Market Forecast
10.5.5 GCC Countries Oncolytic Virus Immunotherapy Market Forecast
10.6 Global Oncolytic Virus Immunotherapy Forecast by Type (2025-2030)
10.7 Global Oncolytic Virus Immunotherapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Oncolytic Virus Immunotherapy Product Offered
11.1.3 Merck Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Oncolytic Virus Immunotherapy Product Offered
11.2.3 Amgen Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 TILT Biotherapeutics
11.3.1 TILT Biotherapeutics Company Information
11.3.2 TILT Biotherapeutics Oncolytic Virus Immunotherapy Product Offered
11.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 TILT Biotherapeutics Main Business Overview
11.3.5 TILT Biotherapeutics Latest Developments
11.4 Oncorus
11.4.1 Oncorus Company Information
11.4.2 Oncorus Oncolytic Virus Immunotherapy Product Offered
11.4.3 Oncorus Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Oncorus Main Business Overview
11.4.5 Oncorus Latest Developments
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Information
11.5.2 Sorrento Therapeutics Oncolytic Virus Immunotherapy Product Offered
11.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sorrento Therapeutics Main Business Overview
11.5.5 Sorrento Therapeutics Latest Developments
11.6 Shanghai Sunway Biotech
11.6.1 Shanghai Sunway Biotech Company Information
11.6.2 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product Offered
11.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Shanghai Sunway Biotech Main Business Overview
11.6.5 Shanghai Sunway Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncolytic Virus Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Engineering Oncolytic Viruses
Table 3. Major Players of Wild-Type Oncolytic Viruses
Table 4. Oncolytic Virus Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 7. Oncolytic Virus Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 10. Global Oncolytic Virus Immunotherapy Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Oncolytic Virus Immunotherapy Revenue Market Share by Player (2019-2024)
Table 12. Oncolytic Virus Immunotherapy Key Players Head office and Products Offered
Table 13. Oncolytic Virus Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Oncolytic Virus Immunotherapy Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Oncolytic Virus Immunotherapy Market Size Market Share by Regions (2019-2024)
Table 18. Global Oncolytic Virus Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Oncolytic Virus Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Oncolytic Virus Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Oncolytic Virus Immunotherapy Market Size Market Share by Country (2019-2024)
Table 22. Americas Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 24. Americas Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 26. APAC Oncolytic Virus Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Region (2019-2024)
Table 28. APAC Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 30. APAC Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 32. Europe Oncolytic Virus Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Country (2019-2024)
Table 34. Europe Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 36. Europe Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Oncolytic Virus Immunotherapy
Table 45. Key Market Challenges & Risks of Oncolytic Virus Immunotherapy
Table 46. Key Industry Trends of Oncolytic Virus Immunotherapy
Table 47. Global Oncolytic Virus Immunotherapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Oncolytic Virus Immunotherapy Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Oncolytic Virus Immunotherapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Oncolytic Virus Immunotherapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Merck Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 52. Merck Oncolytic Virus Immunotherapy Product Offered
Table 53. Merck Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Merck Main Business
Table 55. Merck Latest Developments
Table 56. Amgen Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 57. Amgen Oncolytic Virus Immunotherapy Product Offered
Table 58. Amgen Main Business
Table 59. Amgen Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Amgen Latest Developments
Table 61. TILT Biotherapeutics Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 62. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product Offered
Table 63. TILT Biotherapeutics Main Business
Table 64. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. TILT Biotherapeutics Latest Developments
Table 66. Oncorus Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 67. Oncorus Oncolytic Virus Immunotherapy Product Offered
Table 68. Oncorus Main Business
Table 69. Oncorus Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Oncorus Latest Developments
Table 71. Sorrento Therapeutics Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 72. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product Offered
Table 73. Sorrento Therapeutics Main Business
Table 74. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Sorrento Therapeutics Latest Developments
Table 76. Shanghai Sunway Biotech Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 77. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product Offered
Table 78. Shanghai Sunway Biotech Main Business
Table 79. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Shanghai Sunway Biotech Latest Developments
Table 1. Oncolytic Virus Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Engineering Oncolytic Viruses
Table 3. Major Players of Wild-Type Oncolytic Viruses
Table 4. Oncolytic Virus Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 7. Oncolytic Virus Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 10. Global Oncolytic Virus Immunotherapy Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Oncolytic Virus Immunotherapy Revenue Market Share by Player (2019-2024)
Table 12. Oncolytic Virus Immunotherapy Key Players Head office and Products Offered
Table 13. Oncolytic Virus Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Oncolytic Virus Immunotherapy Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Oncolytic Virus Immunotherapy Market Size Market Share by Regions (2019-2024)
Table 18. Global Oncolytic Virus Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Oncolytic Virus Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Oncolytic Virus Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Oncolytic Virus Immunotherapy Market Size Market Share by Country (2019-2024)
Table 22. Americas Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 24. Americas Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 26. APAC Oncolytic Virus Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Region (2019-2024)
Table 28. APAC Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 30. APAC Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 32. Europe Oncolytic Virus Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Country (2019-2024)
Table 34. Europe Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 36. Europe Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Oncolytic Virus Immunotherapy
Table 45. Key Market Challenges & Risks of Oncolytic Virus Immunotherapy
Table 46. Key Industry Trends of Oncolytic Virus Immunotherapy
Table 47. Global Oncolytic Virus Immunotherapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Oncolytic Virus Immunotherapy Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Oncolytic Virus Immunotherapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Oncolytic Virus Immunotherapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Merck Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 52. Merck Oncolytic Virus Immunotherapy Product Offered
Table 53. Merck Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Merck Main Business
Table 55. Merck Latest Developments
Table 56. Amgen Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 57. Amgen Oncolytic Virus Immunotherapy Product Offered
Table 58. Amgen Main Business
Table 59. Amgen Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Amgen Latest Developments
Table 61. TILT Biotherapeutics Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 62. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product Offered
Table 63. TILT Biotherapeutics Main Business
Table 64. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. TILT Biotherapeutics Latest Developments
Table 66. Oncorus Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 67. Oncorus Oncolytic Virus Immunotherapy Product Offered
Table 68. Oncorus Main Business
Table 69. Oncorus Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Oncorus Latest Developments
Table 71. Sorrento Therapeutics Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 72. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product Offered
Table 73. Sorrento Therapeutics Main Business
Table 74. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Sorrento Therapeutics Latest Developments
Table 76. Shanghai Sunway Biotech Details, Company Type, Oncolytic Virus Immunotherapy Area Served and Its Competitors
Table 77. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product Offered
Table 78. Shanghai Sunway Biotech Main Business
Table 79. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Shanghai Sunway Biotech Latest Developments
LIST OF FIGURES
Figure 1. Oncolytic Virus Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Immunotherapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oncolytic Virus Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncolytic Virus Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. Oncolytic Virus Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncolytic Virus Immunotherapy Market Size Market Share by Type in 2023
Figure 10. Oncolytic Virus Immunotherapy in Hospitals
Figure 11. Global Oncolytic Virus Immunotherapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Oncolytic Virus Immunotherapy in Clinics
Figure 13. Global Oncolytic Virus Immunotherapy Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Oncolytic Virus Immunotherapy in Ambulatory Surgical Centers
Figure 15. Global Oncolytic Virus Immunotherapy Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 16. Global Oncolytic Virus Immunotherapy Market Size Market Share by Application in 2023
Figure 17. Global Oncolytic Virus Immunotherapy Revenue Market Share by Player in 2023
Figure 18. Global Oncolytic Virus Immunotherapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Oncolytic Virus Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Oncolytic Virus Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Oncolytic Virus Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Oncolytic Virus Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Oncolytic Virus Immunotherapy Value Market Share by Country in 2023
Figure 24. United States Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Region in 2023
Figure 29. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Type in 2023
Figure 30. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Application in 2023
Figure 31. China Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Country in 2023
Figure 38. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 61. China Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 65. India Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 68. France Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Oncolytic Virus Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Oncolytic Virus Immunotherapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Oncolytic Virus Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Immunotherapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oncolytic Virus Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncolytic Virus Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. Oncolytic Virus Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncolytic Virus Immunotherapy Market Size Market Share by Type in 2023
Figure 10. Oncolytic Virus Immunotherapy in Hospitals
Figure 11. Global Oncolytic Virus Immunotherapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Oncolytic Virus Immunotherapy in Clinics
Figure 13. Global Oncolytic Virus Immunotherapy Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Oncolytic Virus Immunotherapy in Ambulatory Surgical Centers
Figure 15. Global Oncolytic Virus Immunotherapy Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 16. Global Oncolytic Virus Immunotherapy Market Size Market Share by Application in 2023
Figure 17. Global Oncolytic Virus Immunotherapy Revenue Market Share by Player in 2023
Figure 18. Global Oncolytic Virus Immunotherapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Oncolytic Virus Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Oncolytic Virus Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Oncolytic Virus Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Oncolytic Virus Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Oncolytic Virus Immunotherapy Value Market Share by Country in 2023
Figure 24. United States Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Region in 2023
Figure 29. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Type in 2023
Figure 30. APAC Oncolytic Virus Immunotherapy Market Size Market Share by Application in 2023
Figure 31. China Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Country in 2023
Figure 38. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Oncolytic Virus Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 61. China Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 65. India Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 68. France Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Oncolytic Virus Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Oncolytic Virus Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Oncolytic Virus Immunotherapy Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Magnetic Bead Purification Kits Market Growth 2025-2031
US$ 3,660.00
January 2025
136 pages
Global Endodontic Irrigation Needles Market Growth 2024-2030
US$ 3,660.00
October 2024
93 pages
Global Medical Hair Removal Equipment Market Growth 2024-2030
US$ 3,660.00
March 2024
109 pages
Global Reusable Cage Laboratory Animal Housing Cage Market Growth 2025-2031
US$ 3,660.00
August 2025
109 pages
